Page | |
EDITORIALS |
589 | Recommendations from The Medical Education Editor
|
592 | Asthma research priorities: Listening to everybody
|
594 | Gait speed in idiopathic pulmonary fibrosis: Quickly stepping in the right direction
|
597 | Seeing through a glass darkly: Uncertainties about palliative care for patients with interstitial lung disease
|
COMMENTARY |
599 | Hypersensitivity pneumonitis: Principles in diagnosis and management
|
INVITED REVIEW SERIES |
The Future of Asthma |
603 | Covid-19 pandemic and asthma: What did we learn?
|
INVITED REVIEWS |
615 | Vocal cord dysfunction/inducible laryngeal obstruction—2022 Melbourne Roundtable Report
Paul Leong, Peter G Gibson, Anne E Vertigan, Mark Hew, Vanessa M McDonald, Philip G Bardin
10.1111/resp.14518 |
627 | Contemporary Concise Review 2022: Interstitial lung disease
|
ORIGINAL ARTICLES |
Asthma and Allergy |
636 |
Identifying the asthma research priorities of people with asthma, their carers and other stakeholders
Eleanor C Majellano, Rose L Bell, Anthony W Flynn, Anne Mckenzie, Sundram Sivamalai, Michele Goldman, Lauren Vaughan, Peter G Gibson
10.1111/resp.14492
The burden of asthma is an ongoing challenge. We established Australia's top 10 asthma research priorities. Using a rigorous methodology to capture the voice of end-users can be useful to focus research on what matters to the people who rely on it.
See related editorial |
Interstitial Lung Disease |
649 | Change in gait speed and adverse outcomes in patients with idiopathic pulmonary fibrosis: A prospective cohort study
Claire M Nolan, Susie J Schofield, Matthew Maddocks, Suhani Patel, Ruth E Barker, Jessica A Walsh, Oliver Polgar, Peter M George, Philip L Molyneaux, Toby M Maher, Paul Cullinan, William D-C Man
10.1111/resp.14494
In people newly diagnosed with IPF, four-metre gait speed (4MGS) declined significantly over 6 months. A decline of more than 0.07 m/s was associated with shorter time to hospitalization/death over the subsequent 6 months. 4MGS change has potential as a surrogate endpoint for interventions aimed at modifying hospitalization/death in IPF.
See related editorial |
659 | Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists
Tomoyuki Fujisawa, Norimichi Akiyama, Tatsuya Morita, Takafumi Koyauchi, Yoshinobu Matsuda, Masanori Mori, Mitsunori Miyashita, Ryo Tachikawa, Keisuke Tomii, Hiromi Tomioka, Satoshi Hagimoto, Yasuhiro Kondoh, Yoshikazu Inoue, Takafumi Suda
10.1111/resp.14493
Pulmonary specialists experienced greater difficulty, including ILD-specific barriers, in providing palliative care for patients with ILD compared to those with lung cancer. The timing of end-of-life communication was later than the physician-perceived ideal timing in ILD. Multifaceted clinical studies are needed to develop optimal palliative care for patients with ILD.
See related editorial |
Lung Cancer |
669 | Prediction model on disease recurrence for low risk resected stage I lung adenocarcinoma
Wang Chun Kwok, Ting Fung Ma, James Chung Man Ho, David Chi Leung Lam, Ko Yung Sit, Mary Sau Man Ip, Timmy Wing Kuk Au, Terence Chi Chun Tam
10.1111/resp.14508
We developed a post-operative prediction model for patients with stage I adenocarcinoma based on readily available clinical information, including smoking status, disease stage and gender. The model may help personalize a follow-up strategy and future adjuvant therapy. |
FORUM AND DEBATE |
Scientific Letter |
677 | Eosinopenia is associated with adverse outcomes after COVID-19 infection: A perspective from Japan
Akihiro Ito, Tadashi Ishida, Yosuke Nakanishi, Hiroshi Kobe, Fumiaki Tokioka
10.1111/resp.14509 |
Personal Reflections |
681 | Smoking: Quit to win
|
683 | Let us start thinking about what to do in the event of a global influenza pandemic
|
685 | The 63rd Annual Meeting of the Japanese Respiratory Society
|
CORRIGENDUM |
686 | Corrigendum
10.1111/resp.14521
This article corrects the following:
Effects of chemical composition on the lung cell response to coal particles: Implications for coal workers' pneumoconiosis
10.1111/resp.14246 |